Skip to main content

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1425))

Abstract

Drug discovery and development is a costly and time-consuming endeavor (Calcoen et al. Nat Rev Drug Discov 14(3):161–162, 2015; The truly staggering cost of inventing new drugs. Forbes. http://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/, 2012; Scannell et al. Nat Rev Drug Discov 11(3):191–200, 2012). Over the last two decades, computational tools and in silico models to predict ADMET (Adsorption, Distribution, Metabolism, Excretion, and Toxicity) profiles of molecules have been incorporated into the drug discovery process mainly in an effort to avoid late-stage failures due to poor pharmacokinetics and toxicity. It is now widely recognized that ADMET issues should be addressed as early as possible in drug discovery. Here, we describe in detail how ADMET models can be developed and applied using a commercially available package, ADMET Predictor™ 7.2 (ADMET Predictor v7.2. Simulations Plus, Inc., Lancaster, CA, USA).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Calcoen D, Elias L, Yu X (2015) What does it take to produce a breakthrough drug? Nat Rev Drug Discov 14(3):161–162

    Article  PubMed  Google Scholar 

  2. The truly staggering cost of inventing new drugs (2012) Forbes. http://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/

  3. Scannell JW, Blanckley A, Boldon H, Warrington B (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11(3):191–200

    Article  CAS  PubMed  Google Scholar 

  4. ADMET Predictor v7.2, Simulations Plus, Inc.: Lancaster, CA, USA

    Google Scholar 

  5. Directory of computer-aided Drug Design tools. (2014) http://www.click2drug.org/directory_ADMET.html

  6. Dalby A, Nourse JG, Hounshell WD, Gushurst AKI, Grier DL, Leland BA, Laufer J (1991) Description of Several Chemical Structure File Formats Used by Computer Programs Developed at Molecular Design Limited. J Chem Inf Comput Sci 32(3):245–260

    Google Scholar 

  7. Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comp Sci 28:31–36

    Article  CAS  Google Scholar 

  8. Weininger D, Weininger A, Weininger JL (1989) SMILES. 2. Algorithm for generation of unique SMILES notation. J Chem Inf Comp Sci 29:97–101

    Article  CAS  Google Scholar 

  9. SMILES (2007) Daylight Chemical Information Systems. Inc, www.daylight.com/smiles/index.html

  10. MedChem Designer v3.0, Simulations Plus, Inc.: Lancaster, CA, USA

    Google Scholar 

  11. ChemDraw v15.0, PerkinElmer: Waltham, MA, USA

    Google Scholar 

  12. Accelrys Draw v4.1, Biovia: San Diego, CA, USA

    Google Scholar 

  13. Biovia Insight v1.0, Biovia: San Diego, CA, USA

    Google Scholar 

  14. Pipeline Pilot v9.0, Biovia: San Diego, CA, USA

    Google Scholar 

  15. Michaelis L, Menten M (1913) Die Kinetik der Invertinwirkung. Biochem Z 49:333–339

    CAS  Google Scholar 

  16. GastroPlus v9.0, Simulations Plus, Inc.: Lancaster, CA, USA

    Google Scholar 

  17. Kohonen T (1982) Self-Organized Formation of Topologically Correct Feature Maps. Biol Cybern 43:59–69

    Article  Google Scholar 

  18. World Drug Index v2007/04, Thomson Scientific: London, UK

    Google Scholar 

  19. Yoshii K, Kobayashi K, Tsumuji M, Tani M, Shimada N, Chiba K (2000) Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes. Life Sci 67:175–184

    Article  CAS  PubMed  Google Scholar 

  20. Wójcikowski J, Pichard-Garcia L, Maurel P, Daniel WA (2003) Contribution of human cytochrome P-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Br J Pharmacol 138(8):1465–1474

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wójcikowski J, Pichard-Garcia L, Maurel P, Daniel WA (2004) The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Eur Neuropsychopharmacol 14(3):199–208

    Article  PubMed  Google Scholar 

  22. Wojcikowski J, Boksa J, Daniel WA (2010) Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver—A comparison with other phenothiazines. Biochem Pharmacol 80:1252–1259

    Article  CAS  PubMed  Google Scholar 

  23. Cashman JR, Yang Z, Yang L, Wrighton SA (1993) Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes. Drug Metab Dispos 21(3):492–501

    CAS  PubMed  Google Scholar 

  24. Morel E, Lloyd KG, Dahl SG (1987) Anti-apomorphine effects of phenothiazine drug metabolites. Psychopharmacology (Berl) 92(1):68–72

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Fraczkiewicz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Ghosh, J., Lawless, M.S., Waldman, M., Gombar, V., Fraczkiewicz, R. (2016). Modeling ADMET. In: Benfenati, E. (eds) In Silico Methods for Predicting Drug Toxicity. Methods in Molecular Biology, vol 1425. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3609-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3609-0_4

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3607-6

  • Online ISBN: 978-1-4939-3609-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics